Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Ziff Davis Q4 and FY2025 Earnings Call - Search-driven Affiliate Hit Keeps Tech & Shopping in the Doghouse
Ziff Davis posted modest full-year growth while a search-driven collapse in affiliate commerce carved into Q4 results. FY2025 revenue rose 3.5% to $1.45 billion and adjusted EBITDA edged up to $495.1 ...
- Full year 2025 revenue rose 3.5% to $1,451.3 million, and adjusted EBITDA increased to $495.1 million, with an FY adjusted EBITDA margin of 34.1%.
- Q4 2025 revenue was $406.7 million, down 1.5% year-over-year, and Q4 adjusted EBITDA fell 5% to $163.2 million, with a Q4 adjusted EBITDA margin of 40.1%.
- Tech and Shopping was the clear drag, down 18% in Q4, driven primarily by a decline in web search traffic that materially reduced affiliate commerce commissions.
- +14 more takeaways
Arvinas Q4 2025 Earnings Call - Company pivots to four Phase I programs, eyes multiple 2026 data readouts
Arvinas used its Q4 2025 results call to signal a clear strategic reset: the company is now a predominantly Phase I clinical-stage biotech, concentrating resources on four clinical programs while keep...
- Arvinas is repositioned as a Phase I-focused company, concentrating on four clinical programs: ARV-102 (LRRK2), ARV-806 (KRAS G12D), ARV-393 (BCL6) and ARV-027 (polyQ AR for SBMA).
- Management expects multiple meaningful data readouts and clinical advancements across 2026 that will determine program prioritization and value creation.
- ARV-102 (LRRK2 degrader) achieved brain penetration and showed greater than 50% LRRK2 reduction in CSF in earlier studies; patient biomarker data will be presented at the AD/PD conference and a Phase 1b in PSP is planned for H1 2026.
- +11 more takeaways
Scotiabank Q1 2026 Earnings Call - ROE Ahead of Plan as Credit Costs Stay Elevated
Scotiabank posted a strong start to fiscal 2026, delivering adjusted earnings of CAD 2.7 billion and EPS of CAD 2.05, with return on equity at 13% and CET1 at 13.3% after buybacks. Management says the...
- Adjusted net income CAD 2.7 billion, diluted EPS CAD 2.05, up 16% year-over-year, driven by revenue growth and expense control.
- Return on equity 13.0%, up 120 basis points year-over-year, management says ROE is tracking ahead of Investor Day expectations and they have increased confidence in hitting a 14%+ medium-term target.
- CET1 ratio 13.3% after repurchasing 4.9 million shares in Q1 under the NCIB; total buybacks to date were about 15.7 million shares, and management expects to renew the NCIB in May.
- +12 more takeaways
Brightstar Lottery Q4 2025 and FY2025 Earnings Call - Italy Lotto License Recasts Growth, €1.43B Final Installment Hits in Q2 2026
Brightstar completed a strategic transformation in 2025, exiting non-lottery gaming and emerging as a pure-play global lottery operator with stronger leverage metrics, a bigger shareholder-return prog...
- Brightstar completed a portfolio reshape in 2025, divesting the IGT gaming business and positioning itself as a focused, pure-play lottery operator. That strategic tidy-up underpins the company narrative on valuation and capital allocation going forward.
- Brightstar secured the Italy Lotto license for nine years, creating a platform to scale iLottery, iCasino, and sports betting across a retail footprint of over 50,000 points of sale. Management sees Italy as a core multi-year growth engine.
- The Italy license carries large upfront fees. Two installments were paid in 2025 and the final installment is EUR 1.43 billion (Brightstar’s share EUR 880 million, roughly $1 billion), expected to be paid in Q2 2026. That payment will materially affect reported cash from operations and leverage in the short term.
- +12 more takeaways
AdaptHealth Corp Q4 2025 Earnings Call - Largest industry capitated contract goes live early, setting up 2026 revenue and margin ramp
AdaptHealth closed a year of heavy remediation and operational consolidation by standardizing workflows, pruning non-core assets, and bringing the largest capitated HME contract in the industry live a...
- Company implemented a new operating model in 2025, standardizing workflows and centralizing order intake, which management says is driving faster setups and higher conversion rates.
- Full year 2025 revenue was $3.245 billion, Q4 revenue was $846.3 million, and organic revenue growth was 1.7% for both periods, excluding dispositions and acquisitions.
- AdaptHealth set patient census records in Sleep Health, Respiratory Health, and Wellness at Home, and achieved a retention record in Diabetes Health.
- +17 more takeaways
Keurig Dr Pepper Q4 2025 Earnings Call - JDE Peet’s Deal Recasts KDP into Two Pure-Play Companies with Near-Term EPS Accretion
Keurig Dr Pepper closed 2025 with solid top-line momentum and put a stake in the ground for a strategic pivot. Full-year constant currency net sales rose 8.6%, operating income 4.9%, and EPS 7.3%. Man...
- Corporate pivot front and center: KDP launched tender offer to acquire JDE Peet’s, expects early April close, and plans to separate into Beverage Co. and Global Coffee Co. by end of 2026.
- 2025 results: constant currency net sales +8.6%, operating income +4.9%, EPS +7.3% for the full year; Q4 net sales +9.9% and Q4 EPS $0.60, up ~1.7% year over year.
- 2026 guidance inclusive of JDE Peet’s: combined net sales $25.9B–$26.4B, low double-digit constant currency EPS growth; management expects ~6–7 percentage points of EPS contribution from JDE Peet’s over three quarters.
- +12 more takeaways
Henry Schein Fourth Quarter 2025 Earnings Call - Strong Sales Momentum, Back-Loaded Cost Savings and AI-Fueled Growth Guiding 2026
Henry Schein closed Q4 2025 with the strongest sales growth in 15 quarters, driven by record global equipment sales, double-digit gains in select implant brands, and continued traction in cloud practi...
- Q4 global sales were $3.4 billion, up 7.7% year over year, with constant currency growth of 5.8% and a 1.9% FX tailwind.
- Q4 non-GAAP operating margin was 7.42%, relatively flat year over year despite slight gross margin pressure from product mix shifts.
- Q4 GAAP net income was $101 million, or $0.85 per diluted share; Q4 non-GAAP net income was $160 million, or $1.34 per diluted share.
- +15 more takeaways
Orthofix International plc Q4 2025 Earnings Call - Channel Reset Delays Targets One Year, Sets Stage for VIRATA-Fueled Spine Rebound
Orthofix closed Q4 2025 with steady top-line progress and clear operational momentum, but with one important caveat. Management completed a deliberate spine distributor channel reset that pressured ne...
- Q4 2025 pro forma net sales were $218.6 million, up 3% year-over-year, excluding the discontinued M6 disc lines.
- Global spine fixation finished the year with 10% growth; US spine fixation grew 6% for the year and 5% in Q4.
- Management executed a targeted distributor transition in 2025 that caused temporary pressure but is now largely complete; top 30 US spine distributors grew 25% year-over-year and now drive more than 75% of US net sales.
- +15 more takeaways
Novanta Q4 2025 Earnings Call - Record bookings and return to organic growth, but margins and cash hit by a deliberate regionalization choice
Novanta closed 2025 with record revenue and a clear inflection in demand, but the company paid a short-term price for customer-first execution. Q4 delivered 9% reported revenue growth, 2% organic grow...
- Q4 reported revenue grew 9% year-over-year, with 2% organic growth and 4% sequential growth; full-year 2025 revenue was $981 million, the company’s largest ever.
- Bookings jumped 25% year-over-year in Q4 and 12% sequentially, producing a company book-to-bill of 1.11; full-year bookings rose 14% with a book-to-bill of 1.01.
- New product revenue showed strong vitality, up more than 80% in Q4 and over 60% for the full year, lifting the vitality index to 24% in Q4 (22% for the year).
- +12 more takeaways
Cipher Digital Q4 2025 Earnings Call - Pivot Complete: 600 MW of Hyperscale Leases and $9.3B Contracted Revenue
Cipher used Q4 2025 to make its pivot explicit, rebranding to Cipher Digital and shifting from bitcoin mining to hyperscale HPC hosting. The company now has two signed campus leases totaling roughly 6...
- Strategic rebrand to Cipher Digital reflects a completed pivot from bitcoin mining to a pure-play digital infrastructure developer focused on hyperscale HPC.
- Cipher has executed two data center campus leases representing ~600 MW of gross capacity and approximately $9.3 billion in contracted revenue, with initial lease terms of 10 to 15 years and extension options.
- Based solely on executed contracts, management expects roughly $669 million of average annualized net operating income from October 2026 to September 2036, and projects about $754 million in annual NOI by 2035.
- +14 more takeaways